Skip to content

Senate Commerce Committee Holds Hearing on Data and the Coronavirus

April 21, 2020
On April 9, 2020 the U.S. Senate Committee on Commerce, Science and Transportation held a “paper hearing” entitled Enlisting Big Data in the Fight Against Coronavirus. A “paper hearing” consists of the committee members submitting opening statements and witnesses submitting testimony, which were posted on the Committee’s website. Witnesses were required to submit answers to member
Read More

At COVID-19 ‘paper hearing,’ industry, government struggle with balancing privacy, public health

April 17, 2020
With the COVID-19 pandemic preventing large gatherings of any kind, the Senate Committee on Commerce, Science and Transportation last week was forced to hold its hearing on big data and privacy protections in response to the pandemic as a “paper hearing.” Participants submitted written testimony only. Lawmakers sent those experts questions, and the panel responded with written
Read More

Joint Ad Trade Comments on Second Set of Modifications to Proposed CCPA Regulations

March 27, 2020
As the nation’s leading advertising and marketing trade associations, we collectively represent thousands of companies, from small businesses to household brands, across every segment of the advertising industry. We provide the following comments to the California Office of the Attorney General (“OAG”) on the proposed regulation included in 999.315(d) of the March 11, 2020 release
Read More

Ad Trade Testimony on Hawaii HB 2572

March 16, 2020
As the nation’s leading advertising and marketing trade associations, we collectively represent thousands of companies across the country including businesses in Hawaii, from small businesses to household brands, advertising agencies, and technology providers. Our combined membership includes more than 2,500 companies, is responsible for more than 85 percent of the U.S. advertising spend and drives
Read More

NAI Releases Updated Imprecise Location Guidance

March 5, 2020
In the last six months, the NAI has released new Health Targeting Guidance and new Guidance on Opt-in Consent. These activities reflect the flexibility of the NAI’s self-regulatory program to adapt quickly to meet the evolution of technology and business practices, as well as consumer expectations, and to reflect the goals of policymakers and other stakeholders.  Today, the
Read More

Facebook has a prescription: More pharmaceutical ads

March 4, 2020
Jordan Lemasters keeps seeing ads in his Facebook app for an attention-deficit/hyperactivity disorder drug called Vyvanse. When the Chicago-based audio branding consultant recently clicked on the ad’s drop-down menu and selected “Why Am I Seeing This Ad,” a pop-up said it was because of his age range, because he lives in the United States and
Read More